A category-defining innovation in cardiac rhythm management, supported by a portfolio of 41 patents, and an experienced team.
01
A differentiated leadless, self-sustaining pacemaker platform
CAIRDAC is developing ALPS™, an investigational leadless pacemaker platform designed to harvest cardiac kinetic energy and reduce dependence on conventional battery-limited architectures. This positions CAIRDAC in a differentiated segment of cardiac rhythm management.
02
A disruptive piezoelectric energy harvester
CAIRDAC's patented piezoelectric harvester module is designed to convert the heart's mechanical motion into electrical energy. This energy-harvesting architecture creates the potential for advanced pacing, sensing, and communication capabilities beyond conventional battery-limited leadless systems.
03
A rechargeable energy architecture
Existing pacemaker systems rely on primary batteries with finite longevity. ALPS™ is designed around a rechargeable energy reservoir powered by cardiac motion, creating a differentiated architecture for long-term energy management.
04
Energy surplus enabling advanced features
The additional energy is intended to support advanced features that are difficult to implement in current battery-limited leadless devices, including:
Inter-capsule communication enabling multi-chamber pacing
Data storage to support patient follow-up
New sensing capabilities
Other future applications
05
An experienced executive team
CAIRDAC brings together a multidisciplinary team with deep expertise in piezoelectric technologies, cardiac rhythm management, implantable medical devices, clinical development, regulatory affairs, quality and finance.
06
A large and growing pacemaker market
The global pacemaker market was estimated at approximately USD 5.5 billion in 2024 and is projected to reach USD 7.7 billion by 2030, representing a 5.7% CAGR from 2025 to 2030. Growth is supported by ageing populations, rising cardiovascular disease prevalence, technological innovation, and adoption of leadless and remote-monitoring solutions.
07
A consistent portfolio of 41 patents
CAIRDAC has built a robust intellectual property portfolio with 41 patents covering key technology areas, including the piezoelectric harvester, ALPS™ structure and battery architecture, and anchoring system.
08
A clear 5-year development and financing roadmap
The executive team has set up a plan with excellent visibility towards the next steps of product development and team consolidation.
09
An integrated manufacturing and patient-management value chain
CAIRDAC is building an integrated value chain covering device manufacturing, implantation tools, clinician programming, and secure follow-up infrastructure. This approach is designed to support product quality, procedural consistency, and long-term patient management.
CAIRDAC by the numbers
41
Patents in portfolio, covering piezo harvester, ALPS™ structure, battery and anchoring system.
$5.5bn
Estimated global pacemaker market size in 2024, projected to reach USD 7.7bn by 2030.
5.7%
Projected CAGR for the global pacemaker market from 2025 to 2030.
120+
Years of combined expertise in CRM and implantable devices.
Investor relations
Interested in investing in CAIRDAC?
We'd be happy to share our full investor deck and discuss CAIRDAC's roadmap and financing opportunities with you.